APOE and Alzheimer disease: Furthermore, apolipoprotein E3, a high AD-risk marker associating with Aβ depositions, has proven its targeting efficiency for AD brains, and recent study introduced ApoE3-functionalized PBCA nanoparticles to achieve the enhanced uptake by AD brains [63].